A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis. (2020)

First Author: Schmidt WA
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s40744-020-00227-2

PubMed Identifier: 32844378

Publication URI: http://europepmc.org/abstract/MED/32844378

Type: Journal Article/Review

Volume: 7

Parent Publication: Rheumatology and therapy

Issue: 4

ISSN: 2198-6576